UBS’s Immutep IMMP Stock Holding History

UBS’s Portfolio IMMP Stock Details IMMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$8K	Sell	121 -27	-18%	-$1.97K	﹤0.01%	9038
2014 Q2	$11K	Buy	148 +96	+185%	+$7.42K	﹤0.01%	8778
2014 Q1	$4K	Buy	52 +6	+13%	+$500	﹤0.01%	9684
2013 Q4	$3K	Sell	46 -19	-29%	-$1.4K	﹤0.01%	9858
2013 Q3	$5K	Buy	65 +45	+225%	+$7.02K	﹤0.01%	9412
2013 Q2	$3K	Buy	+20	New	+$3.49K	﹤0.01%	9607

Other funds holding IMMP

Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

UBS's IMMP Position: Q3 2014 in Review

UBS reduced its Immutep (IMMP) stake by 18% in Q3 2014, selling an estimated $1.97K and leaving 121 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #9038.

UBS first reported a position in IMMP in Q2 2013 and has held it in 6 quarters since. The position peaked at $11K in Q2 2014. 5 funds tracked by Wall St. Rank hold IMMP as of Q3 2014.

UBS held 121 shares of Immutep worth $8K as of Q3 2014.
UBS sold 27 Immutep shares in Q3 2014, an estimated $1.97K.
Immutep made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9038 holding.
UBS first reported a position in Immutep in Q2 2013 and has held it in 6 quarters since.
UBS's Immutep position peaked at $11K in Q2 2014.
5 funds tracked by Wall St. Rank held Immutep as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.